自拟脂康饮治疗慢性乙型病毒性肝炎合并脂肪肝35例临床观察

The Clinical Research of Zhikangyin on Chronic Hepatitis B with Non-Alcoholic Fatty Liver Disease: A Clinical Observation of 35 Cases

目的:观察自拟脂康饮治疗慢性乙型病毒性肝炎合并脂肪肝的疗效。方法:将70例本病患者随机分为治疗组和对照组各35例。治疗组予西药联合自拟脂康饮加减治疗,对照组予西药治疗。以8周为1个观察周期。结果:治疗组血脂、肝功能指标均明显降低,治疗后两组比较,差异有统计学意义(P<0.05);治疗组总有效率为88.6%,对照组总有效率为60.0%,两组比较,差异有统计学意义(P<0.05)。结论:自拟脂康饮治疗慢性乙型病毒性肝炎合并脂肪肝有较好疗效。

Objective： To observe clinical efficacy of Zhikangyin（ZKY）on chronic hepatitis B with fatty liver disease. Meth- ods： 70 patients were randomly divided into treatment and control group, 35 cases in each group. Patients were treated by western medicine combined variation of Zhikangyin, and western medicine in control group. The observation course was 8 weeks. Results： The blood lipid and liver function indices in treatment group reduced significantly, and the cooperation of two groups after treatment showed statistically difference （P〈0.05）; The total effectiveness was 88.6% and 60.0% respectively in treatment and control group, and there was significant difference （P〈0.05）. Conclusion： Zhikangyin can provide obvious curative effect for chronic hepatitis B patients with non-alcoholic fatty liver disease.